311 related articles for article (PubMed ID: 26149023)
1. Tranexamic acid in trauma: how should we use it?
Roberts I
J Thromb Haemost; 2015 Jun; 13 Suppl 1():S195-9. PubMed ID: 26149023
[TBL] [Abstract][Full Text] [Related]
2. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C
Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a prognostic model to predict death in patients with traumatic bleeding, and evaluation of the effect of tranexamic acid on mortality according to baseline risk: a secondary analysis of a randomised controlled trial.
Perel P; Prieto-Merino D; Shakur H; Roberts I
Health Technol Assess; 2013 Jun; 17(24):1-45, v-vi. PubMed ID: 23782457
[TBL] [Abstract][Full Text] [Related]
4. Severely injured trauma patients with admission hyperfibrinolysis: Is there a role of tranexamic acid? Findings from the PROPPR trial.
Khan M; Jehan F; Bulger EM; OʼKeeffe T; Holcomb JB; Wade CE; Schreiber MA; Joseph B;
J Trauma Acute Care Surg; 2018 Nov; 85(5):851-857. PubMed ID: 29985230
[TBL] [Abstract][Full Text] [Related]
5. Antifibrinolytic drugs for acute traumatic injury.
Ker K; Roberts I; Shakur H; Coats TJ
Cochrane Database Syst Rev; 2015 May; 2015(5):CD004896. PubMed ID: 25956410
[TBL] [Abstract][Full Text] [Related]
6. Tranexamic acid in bleeding trauma patients: an exploration of benefits and harms.
Roberts I; Edwards P; Prieto D; Joshi M; Mahmood A; Ker K; Shakur H
Trials; 2017 Jan; 18(1):48. PubMed ID: 28143564
[TBL] [Abstract][Full Text] [Related]
7. Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial.
Brenner A; Belli A; Chaudhri R; Coats T; Frimley L; Jamaluddin SF; Jooma R; Mansukhani R; Sandercock P; Shakur-Still H; Shokunbi T; Roberts I;
Crit Care; 2020 Nov; 24(1):560. PubMed ID: 33172504
[TBL] [Abstract][Full Text] [Related]
8. Tranexamic Acid Update in Trauma.
Ramirez RJ; Spinella PC; Bochicchio GV
Crit Care Clin; 2017 Jan; 33(1):85-99. PubMed ID: 27894501
[TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis.
McCormack PL
Drugs; 2012 Mar; 72(5):585-617. PubMed ID: 22397329
[TBL] [Abstract][Full Text] [Related]
10. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.
; Roberts I; Shakur H; Afolabi A; Brohi K; Coats T; Dewan Y; Gando S; Guyatt G; Hunt BJ; Morales C; Perel P; Prieto-Merino D; Woolley T
Lancet; 2011 Mar; 377(9771):1096-101, 1101.e1-2. PubMed ID: 21439633
[TBL] [Abstract][Full Text] [Related]
11. Antifibrinolytic drugs for acute traumatic injury.
Roberts I; Shakur H; Ker K; Coats T;
Cochrane Database Syst Rev; 2012; 12():CD004896. PubMed ID: 23418644
[TBL] [Abstract][Full Text] [Related]
12. Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial.
Roberts I; Perel P; Prieto-Merino D; Shakur H; Coats T; Hunt BJ; Lecky F; Brohi K; Willett K;
BMJ; 2012 Sep; 345():e5839. PubMed ID: 22968527
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid in trauma: After 3 hours from injury, when is it safe and effective to use again?
Barrett CD; Neal MD; Schoenecker JG; Medcalf RL; Myles PS
Transfusion; 2024 May; 64 Suppl 2():S11-S13. PubMed ID: 38461482
[TBL] [Abstract][Full Text] [Related]
14. Antifibrinolytic drugs for acute traumatic injury.
Roberts I; Shakur H; Ker K; Coats T;
Cochrane Database Syst Rev; 2011 Jan; (1):CD004896. PubMed ID: 21249666
[TBL] [Abstract][Full Text] [Related]
15. Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial.
Brenner A; Afolabi A; Ahmad SM; Arribas M; Chaudhri R; Coats T; Cuzick J; Gilmore I; Hawkey C; Jairath V; Javaid K; Kayani A; Mutti M; Nadeem MA; Shakur-Still H; Stanworth S; Veitch A; Roberts I;
Trials; 2019 Jul; 20(1):467. PubMed ID: 31362765
[TBL] [Abstract][Full Text] [Related]
16. Tranexamic Acid for Acute Hemorrhage: A Narrative Review of Landmark Studies and a Critical Reappraisal of Its Use Over the Last Decade.
Lier H; Maegele M; Shander A
Anesth Analg; 2019 Dec; 129(6):1574-1584. PubMed ID: 31743178
[TBL] [Abstract][Full Text] [Related]
17. Trauma and severe bleeding. Tranexamic acid within one hour to reduce mortality.
Prescrire Int; 2013 Jul; 22(140):189-90. PubMed ID: 23951599
[TBL] [Abstract][Full Text] [Related]
18. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2) A randomised, placebo-controlled trial.
Williams-Johnson JA; McDonald AH; Strachan GG; Williams EW
West Indian Med J; 2010 Dec; 59(6):612-24. PubMed ID: 21702233
[TBL] [Abstract][Full Text] [Related]
19. Effect of tranexamic acid on intracranial haemorrhage and infarction in patients with traumatic brain injury: a pre-planned substudy in a sample of CRASH-3 trial patients.
Mahmood A; Needham K; Shakur-Still H; Harris T; Jamaluddin SF; Davies D; Belli A; Mohamed FL; Leech C; Lotfi HM; Moss P; Lecky F; Hopkins P; Wong D; Boyle A; Wilson M; Darwent M; Roberts I
Emerg Med J; 2021 Apr; 38(4):270-278. PubMed ID: 33262252
[TBL] [Abstract][Full Text] [Related]
20. Tranexamic acid is associated with reduced complement activation in trauma patients with hemorrhagic shock and hyperfibrinolysis on thromboelastography.
Barrett CD; Vigneshwar N; Moore HB; Ghasabyan A; Chandler J; Moore EE; Yaffe MB
Blood Coagul Fibrinolysis; 2020 Dec; 31(8):578-582. PubMed ID: 32732500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
